Related Experiment Video
Updated: Feb 12, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Successful management of lymphangiosarcoma in a puppy using a tyrosine kinase inhibitor
Ji-Hyun Kim1, Hakyoung Yoon1, Hun-Young Yoon1
1Department of Veterinary Surgery (Ji-Hyun Kim, H-Y Yoon), Department of Veterinary Medical Imaging (H Yoon, Eom), Department of Veterinary Internal Medicine (Sung, Jung-Hyun Kim), College of Veterinary Medicine, Konkuk University, #120 Neungdong-ro, Gwangjin-gu, Seoul, 143-701, Korea.
Abstract:
A puppy was diagnosed with lymphangiosarcoma associated with lymphedema based on lymphography and histopathology. The lesions resolved after toceranib therapy, and the dog remains in remission 1 year later. This is the first report of a successful outcome following oral toceranib as first-line therapy for lymphangiosarcoma in a dog.
Related Concept Videos
Receptor Tyrosine Kinases
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Ecological Succession
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

